The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis
Authors:
- Hongzhao LiHLHongzhao Li
- Liangyou GuLGLiangyou Gu
- Xin MaXMXin Ma
- Xintao LiXLXintao Li
- Yu GaoYGYu Gao
- Yu ZhangYZYu Zhang
- Donglai ShenDSDonglai Shen
- Yang FanYFYang Fan
- Baojun WangBWBaojun Wang
- Xu BaoXBXu Bao
- Xu ZhangXZXu Zhang
Open Access
- 1 July 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (26) , e1055
Abstract
Previous studies that investigated the relationship between DM and survival in renal cell carcinoma (RCC) patients reported inconsistent findings. Hence, we conducted a meta-analysis to obtain a more precise evaluation of the prognostic significance of DM in RCC. A systematic review was conducted with PubMed, Embase, and Web of Science to identify relevant articles that evaluated the effect of DM on RCC patients. Based on the inclusion and quality assessment criteria, 18 studies were eligible for the meta-analysis. Pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) for overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were calculated by standard meta-analysis techniques. The results suggested that DM was associated with poor OS (HR 1.56, 95% CI, 1.35–1.81, P < 0.001), poor CSS (HR 2.03, 95% CI, 1.37–3.01, P < 0.001), and poor RFS (HR 1.73, 95% CI, 1.25–2.39, P = 0.012). In addition, for patients with localized RCC, patients with clear cell RCC, or patients receiving nephrectomy, DM was associated with both poor OS and CSS by subgroup analyses. Our study revealed that there was a significant negative impact of DM on OS, CSS, and RFS in RCC patients. Therefore, more attention should be paid to RCC patients with preexisting DM because of their poor prognosis.Keywords
This publication has 42 references indexed in Scilit:
- Multi-Institutional Analysis of Localized Renal Cell Carcinoma that Demonstrates the Impact of Diabetic Status on Prognosis After NephrectomyAnnals of Surgical Oncology, 2013
- Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitroBMC Cancer, 2013
- Lymphopenia is an Independent Predictor of Inferior Outcome in Clear Cell Renal CarcinomaJournal of Urology, 2013
- Influence of Body Mass Index, Smoking, and Blood Pressure on Survival of Patients with Surgically-Treated, Low Stage Renal Cell Carcinoma: A 14-Year Retrospective Cohort StudyJournal of Korean Medical Science, 2013
- Effect of Type 2 Diabetes Mellitus on Prognosis of Nonmetastatic Renal Cell CancerKorean Journal of Urology, 2013
- Body mass index and survival in patients with renal cell carcinoma: A clinical‐based cohort and meta‐analysisInternational Journal of Cancer, 2012
- AKI and stem cellsNephrology Dialysis Transplantation, 2012
- Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific regionAnnals of Oncology, 2010
- Diabetes and CancerDiabetes Care, 2010
- Measuring inconsistency in meta-analysesBMJ, 2003